52/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q20/3 |
LoseTHO / S&P -5.28% / 15.20% |
LoseTHO / S&P 2.40% / 15.00% |
LoseTHO / S&P 18.94% / 50.40% |
Non-scoringTHO / S&P 2.67% / 15.70% | Non-scoringTHO / S&P 15.84 / 28.47 | Non-scoringTHO / S&P 0.96 / S&P unavailable | Non-scoringTHO / S&P THO unavailable / S&P unavailable | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.36b |
| 2026-Q11/3 |
LoseTHO / S&P -21.80% / -4.33% |
LoseTHO / S&P 4.61% / 11.30% |
WinTHO / S&P 49.34% / 27.70% |
Non-scoringTHO / S&P 3.02% / 14.80% | Non-scoringTHO / S&P 19.68 / 25.43 | Non-scoringTHO / S&P 1.37 / S&P unavailable | Non-scoringTHO / S&P THO unavailable / S&P unavailable | Non-scoringTHO / S&P THO unavailable / $0.27b | Non-scoringTHO / S&P THO unavailable / $0.00b |
| 2025-Q41/3 |
LoseTHO / S&P -0.51% / 2.65% |
LoseTHO / S&P 1.45% / 9.00% |
WinTHO / S&P 35.04% / 13.40% |
Non-scoringTHO / S&P 2.87% / 13.20% | Non-scoringTHO / S&P 19.47 / 28.48 | Non-scoringTHO / S&P 1.28 / 5.39 | Non-scoringTHO / S&P THO unavailable / $4.42m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.20b |
| 2025-Q31/3 |
WinTHO / S&P 17.42% / 8.12% |
LoseTHO / S&P -4.62% / 4.61% |
LoseTHO / S&P -1.83% / 13.45% |
Non-scoringTHO / S&P 2.70% / 11.78% | Non-scoringTHO / S&P 18.72 / 28.13 | Non-scoringTHO / S&P 1.13 / 5.27 | Non-scoringTHO / S&P THO unavailable / $4.42m | Non-scoringTHO / S&P THO unavailable / $0.11b | Non-scoringTHO / S&P THO unavailable / $0.00b |
| 2025-Q21/3 |
WinTHO / S&P 17.99% / 10.94% |
LoseTHO / S&P -6.42% / 4.83% |
LoseTHO / S&P -15.42% / 10.63% |
Non-scoringTHO / S&P 2.32% / 11.45% | Non-scoringTHO / S&P 17.29 / 27.10 | Non-scoringTHO / S&P 0.91 / 5.01 | Non-scoringTHO / S&P THO unavailable / $4.42m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.23b |
| 2025-Q10/3 |
LoseTHO / S&P -20.38% / -4.27% |
LoseTHO / S&P -8.47% / 4.98% |
LoseTHO / S&P -25.20% / 10.57% |
Non-scoringTHO / S&P 2.13% / 11.39% | Non-scoringTHO / S&P 27.08 / 26.23 | Non-scoringTHO / S&P 1.38 / 4.69 | Non-scoringTHO / S&P THO unavailable / $4.42m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.10b |
| 2024-Q40/3 |
LoseTHO / S&P -12.48% / 2.41% |
LoseTHO / S&P -7.88% / 5.25% |
LoseTHO / S&P -27.73% / 6.15% |
Non-scoringTHO / S&P 2.17% / 11.29% | Non-scoringTHO / S&P 26.24 / 28.60 | Non-scoringTHO / S&P 1.36 / 4.99 | Non-scoringTHO / S&P THO unavailable / $4.28m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.08b |
| 2024-Q31/3 |
WinTHO / S&P 18.20% / 5.89% |
LoseTHO / S&P -9.69% / 5.89% |
LoseTHO / S&P -29.06% / 6.11% |
Non-scoringTHO / S&P 2.64% / 10.87% | Non-scoringTHO / S&P 21.28 / 28.09 | Non-scoringTHO / S&P 1.39 / 4.94 | Non-scoringTHO / S&P THO unavailable / $4.28m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.21b |
| 2024-Q20/3 |
LoseTHO / S&P -20.02% / 4.28% |
LoseTHO / S&P -16.04% / 5.38% |
LoseTHO / S&P -52.69% / 5.12% |
Non-scoringTHO / S&P 2.59% / 10.85% | Non-scoringTHO / S&P 19.96 / 27.64 | Non-scoringTHO / S&P 1.32 / 4.79 | Non-scoringTHO / S&P THO unavailable / $4.28m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.36b |
| 2024-Q10/3 |
LoseTHO / S&P -0.77% / 10.56% |
LoseTHO / S&P -25.54% / 5.71% |
LoseTHO / S&P -65.24% / 5.59% |
Non-scoringTHO / S&P 2.62% / 10.81% | Non-scoringTHO / S&P 22.17 / 27.02 | Non-scoringTHO / S&P 1.53 / 4.71 | Non-scoringTHO / S&P THO unavailable / $4.28m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.12b |
| 2023-Q41/3 |
WinTHO / S&P 25.50% / 11.69% |
LoseTHO / S&P -32.00% / 6.81% |
LoseTHO / S&P -71.21% / 7.78% |
Non-scoringTHO / S&P 2.77% / 11.19% | Non-scoringTHO / S&P 16.07 / 24.35 | Non-scoringTHO / S&P 1.20 / 4.31 | Non-scoringTHO / S&P THO unavailable / $4.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.01b |
| 2023-Q30/3 |
LoseTHO / S&P -7.68% / -3.27% |
LoseTHO / S&P -31.82% / 7.52% |
LoseTHO / S&P -66.26% / -5.03% |
Non-scoringTHO / S&P 3.37% / 10.84% | Non-scoringTHO / S&P 16.45 / 23.93 | Non-scoringTHO / S&P 1.55 / 3.98 | Non-scoringTHO / S&P THO unavailable / $4.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.24b |
| 2023-Q21/3 |
WinTHO / S&P 30.71% / 8.74% |
LoseTHO / S&P -24.11% / 9.50% |
LoseTHO / S&P -46.78% / -8.57% |
Non-scoringTHO / S&P 4.63% / 10.88% | Non-scoringTHO / S&P 7.49 / 24.01 | Non-scoringTHO / S&P 1.09 / 4.19 | Non-scoringTHO / S&P THO unavailable / $4.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.17b |
| 2023-Q11/3 |
LoseTHO / S&P 5.50% / 7.50% |
LoseTHO / S&P -6.39% / 10.77% |
WinTHO / S&P -12.39% / -15.69% |
Non-scoringTHO / S&P 5.69% / 10.82% | Non-scoringTHO / S&P 6.44 / 22.66 | Non-scoringTHO / S&P 1.35 / 3.93 | Non-scoringTHO / S&P THO unavailable / $4.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.13b |
| 2022-Q43/3 |
WinTHO / S&P 9.15% / 7.56% |
WinTHO / S&P 12.55% / 11.88% |
WinTHO / S&P 32.89% / -17.99% |
Non-scoringTHO / S&P 6.67% / 11.09% | Non-scoringTHO / S&P 4.24 / 22.65 | Non-scoringTHO / S&P 1.20 / 3.75 | Non-scoringTHO / S&P THO unavailable / $3.70m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.15b |
| 2022-Q32/3 |
LoseTHO / S&P -5.81% / -4.88% |
WinTHO / S&P 32.44% / 13.47% |
WinTHO / S&P 73.84% / -1.41% |
Non-scoringTHO / S&P 6.98% / 12.28% | Non-scoringTHO / S&P 4.04 / 20.58 | Non-scoringTHO / S&P 1.28 / 3.60 | Non-scoringTHO / S&P THO unavailable / $3.70m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.17b |
| 2022-Q23/3 |
WinTHO / S&P -4.54% / -16.10% |
WinTHO / S&P 45.57% / 13.71% |
WinTHO / S&P 98.58% / 11.04% |
Non-scoringTHO / S&P 6.76% / 13.03% | Non-scoringTHO / S&P 3.87 / 20.28 | Non-scoringTHO / S&P 1.23 / 3.78 | Non-scoringTHO / S&P THO unavailable / $3.70m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.17b |
| 2022-Q12/3 |
LoseTHO / S&P -24.16% / -4.60% |
WinTHO / S&P 60.56% / 15.97% |
WinTHO / S&P 136.43% / 42.23% |
Non-scoringTHO / S&P 6.20% / 14.22% | Non-scoringTHO / S&P 5.70 / 22.19 | Non-scoringTHO / S&P 1.63 / 4.51 | Non-scoringTHO / S&P THO unavailable / $3.70m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.20b |
| 2021-Q42/3 |
LoseTHO / S&P -14.78% / 11.03% |
WinTHO / S&P 60.75% / 15.00% |
WinTHO / S&P 175.10% / 96.40% |
Non-scoringTHO / S&P 5.74% / 15.13% | Non-scoringTHO / S&P 7.16 / 23.63 | Non-scoringTHO / S&P 1.82 / 4.73 | Non-scoringTHO / S&P THO unavailable / $3.63m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.13b |
| 2021-Q33/3 |
WinTHO / S&P 9.03% / 0.58% |
WinTHO / S&P 50.80% / 10.77% |
WinTHO / S&P 195.51% / 69.42% |
Non-scoringTHO / S&P 5.36% / 14.13% | Non-scoringTHO / S&P 9.93 / 25.35 | Non-scoringTHO / S&P 2.24 / 4.38 | Non-scoringTHO / S&P THO unavailable / $3.63m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.19b |
| 2021-Q22/3 |
LoseTHO / S&P -16.13% / 8.55% |
WinTHO / S&P 35.48% / 6.58% |
WinTHO / S&P 176.19% / 51.81% |
Non-scoringTHO / S&P 4.97% / 13.34% | Non-scoringTHO / S&P 14.29 / 26.70 | Non-scoringTHO / S&P 2.87 / 4.43 | Non-scoringTHO / S&P THO unavailable / $3.63m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.11b |
| 2021-Q13/3 |
WinTHO / S&P 45.34% / 6.17% |
WinTHO / S&P 3.24% / -1.06% |
WinTHO / S&P 87.67% / 7.39% |
Non-scoringTHO / S&P 4.20% / 11.60% | Non-scoringTHO / S&P 17.20 / 30.50 | Non-scoringTHO / S&P 2.61 / 4.23 | Non-scoringTHO / S&P THO unavailable / $3.63m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.10b |
| 2020-Q42/3 |
LoseTHO / S&P -1.52% / 12.15% |
WinTHO / S&P 3.37% / -3.72% |
WinTHO / S&P 65.27% / -33.42% |
Non-scoringTHO / S&P 3.34% / 8.86% | Non-scoringTHO / S&P 16.34 / 39.26 | Non-scoringTHO / S&P 1.95 / 4.05 | Non-scoringTHO / S&P THO unavailable / $3.17m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.01b |
| 2020-Q32/3 |
LoseTHO / S&P -10.58% / 8.93% |
WinTHO / S&P 3.85% / -2.04% |
WinTHO / S&P 63.67% / -27.10% |
Non-scoringTHO / S&P 2.73% / 9.24% | Non-scoringTHO / S&P 28.22 / 34.27 | Non-scoringTHO / S&P 2.71 / 3.65 | Non-scoringTHO / S&P THO unavailable / $3.17m | Non-scoringTHO / S&P THO unavailable / $0.02b | Non-scoringTHO / S&P THO unavailable / $0.00b |
| 2020-Q23/3 |
WinTHO / S&P 155.94% / 20.54% |
WinTHO / S&P 9.80% / -0.46% |
WinTHO / S&P 47.52% / -27.11% |
Non-scoringTHO / S&P 2.40% / 9.37% | Non-scoringTHO / S&P 18.66 / 31.29 | Non-scoringTHO / S&P 1.75 / 3.44 | Non-scoringTHO / S&P THO unavailable / $3.17m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.03b |
| 2020-Q12/3 |
LoseTHO / S&P -43.22% / -19.60% |
WinTHO / S&P 25.21% / 3.47% |
WinTHO / S&P -14.45% / -14.75% |
Non-scoringTHO / S&P 2.28% / 10.68% | Non-scoringTHO / S&P 21.74 / 22.80 | Non-scoringTHO / S&P 2.10 / 2.92 | Non-scoringTHO / S&P THO unavailable / $3.17m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.05b |
| 2019-Q41/3 |
WinTHO / S&P 32.72% / 9.07% |
LoseTHO / S&P 5.28% / 5.36% |
LoseTHO / S&P -47.91% / 2.99% |
Non-scoringTHO / S&P 2.06% / 12.81% | Non-scoringTHO / S&P 20.44 / 22.78 | Non-scoringTHO / S&P 1.65 / 3.53 | Non-scoringTHO / S&P THO unavailable / $3.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.05b |
| 2019-Q30/3 |
LoseTHO / S&P -3.10% / 1.70% |
LoseTHO / S&P -5.57% / 5.02% |
LoseTHO / S&P -69.90% / 0.21% |
Non-scoringTHO / S&P 1.69% / 12.41% | Non-scoringTHO / S&P 24.62 / 22.44 | Non-scoringTHO / S&P 1.57 / 3.30 | Non-scoringTHO / S&P THO unavailable / $3.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.09b |
| 2019-Q20/3 |
LoseTHO / S&P -5.05% / 4.30% |
LoseTHO / S&P THO unavailable / 6.64% |
LoseTHO / S&P -72.28% / 8.65% |
Non-scoringTHO / S&P 1.74% / 12.79% | Non-scoringTHO / S&P 28.02 / 21.37 | Non-scoringTHO / S&P 1.79 / 3.32 | Non-scoringTHO / S&P THO unavailable / $3.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.27b |
| 2019-Q11/3 |
WinTHO / S&P 19.94% / 13.65% |
LoseTHO / S&P THO unavailable / 8.12% |
LoseTHO / S&P -47.53% / 14.29% |
Non-scoringTHO / S&P 3.21% / 12.97% | Non-scoringTHO / S&P 14.92 / 20.86 | Non-scoringTHO / S&P 1.80 / 3.26 | Non-scoringTHO / S&P THO unavailable / $3.08m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $34.35b |
| 2018-Q40/3 |
LoseTHO / S&P -37.04% / -13.52% |
LoseTHO / S&P THO unavailable / 9.05% |
LoseTHO / S&P -25.65% / 18.23% |
Non-scoringTHO / S&P THO unavailable / 13.10% | Non-scoringTHO / S&P THO unavailable / 19.39 | Non-scoringTHO / S&P 1.91 / 2.94 | Non-scoringTHO / S&P THO unavailable / $3.00m | Non-scoringTHO / S&P THO unavailable / $0.01b | Non-scoringTHO / S&P THO unavailable / $0.00b |
| 2018-Q30/3 |
LoseTHO / S&P -14.06% / 7.71% |
LoseTHO / S&P THO unavailable / 10.21% |
LoseTHO / S&P 14.81% / 19.06% |
Non-scoringTHO / S&P THO unavailable / 13.01% | Non-scoringTHO / S&P THO unavailable / 22.25 | Non-scoringTHO / S&P 2.58 / 3.45 | Non-scoringTHO / S&P THO unavailable / $3.00m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.17b |
| 2018-Q21/3 |
LoseTHO / S&P -15.11% / 3.43% |
LoseTHO / S&P THO unavailable / 9.03% |
WinTHO / S&P 36.41% / 14.46% |
Non-scoringTHO / S&P THO unavailable / 12.56% | Non-scoringTHO / S&P THO unavailable / 22.49 | Non-scoringTHO / S&P 3.00 / 3.25 | Non-scoringTHO / S&P THO unavailable / $3.00m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.19b |
| 2018-Q11/3 |
LoseTHO / S&P -23.33% / -0.76% |
LoseTHO / S&P THO unavailable / 7.68% |
WinTHO / S&P 43.77% / 12.46% |
Non-scoringTHO / S&P THO unavailable / 12.27% | Non-scoringTHO / S&P THO unavailable / 23.41 | Non-scoringTHO / S&P 4.12 / 3.17 | Non-scoringTHO / S&P THO unavailable / $3.00m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.08b |
| 2017-Q42/3 |
WinTHO / S&P 20.33% / 6.64% |
LoseTHO / S&P THO unavailable / 7.03% |
WinTHO / S&P 48.70% / 13.82% |
Non-scoringTHO / S&P THO unavailable / 12.09% | Non-scoringTHO / S&P THO unavailable / 24.25 | Non-scoringTHO / S&P 4.26 / 3.23 | Non-scoringTHO / S&P THO unavailable / $2.92m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.05b |
| 2017-Q32/3 |
WinTHO / S&P 20.47% / 4.48% |
LoseTHO / S&P THO unavailable / 5.68% |
WinTHO / S&P 45.59% / 17.57% |
Non-scoringTHO / S&P THO unavailable / 12.04% | Non-scoringTHO / S&P THO unavailable / 23.28 | Non-scoringTHO / S&P 3.51 / 3.08 | Non-scoringTHO / S&P THO unavailable / $2.92m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.11b |
| 2017-Q22/3 |
WinTHO / S&P 9.07% / 3.09% |
LoseTHO / S&P THO unavailable / 4.83% |
WinTHO / S&P 39.13% / 17.74% |
Non-scoringTHO / S&P THO unavailable / 11.96% | Non-scoringTHO / S&P THO unavailable / 23.40 | Non-scoringTHO / S&P 3.44 / 3.03 | Non-scoringTHO / S&P THO unavailable / $2.92m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.08b |
| 2017-Q11/3 |
LoseTHO / S&P -3.59% / 6.07% |
LoseTHO / S&P THO unavailable / 3.67% |
WinTHO / S&P 35.05% / 13.32% |
Non-scoringTHO / S&P THO unavailable / 11.75% | Non-scoringTHO / S&P THO unavailable / 23.60 | Non-scoringTHO / S&P 3.96 / 3.01 | Non-scoringTHO / S&P THO unavailable / $2.92m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $20.24b |
| 2016-Q42/3 |
WinTHO / S&P 18.97% / 3.82% |
LoseTHO / S&P THO unavailable / 2.09% |
WinTHO / S&P 36.02% / 7.05% |
Non-scoringTHO / S&P THO unavailable / 11.37% | Non-scoringTHO / S&P THO unavailable / 23.76 | Non-scoringTHO / S&P 3.15 / 2.91 | Non-scoringTHO / S&P THO unavailable / $2.88m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $1.11b |
| 2016-Q32/3 |
WinTHO / S&P 30.83% / 3.85% |
LoseTHO / S&P THO unavailable / 0.20% |
WinTHO / S&P 30.21% / -3.15% |
Non-scoringTHO / S&P THO unavailable / 10.82% | Non-scoringTHO / S&P THO unavailable / 24.22 | Non-scoringTHO / S&P 3.17 / 2.78 | Non-scoringTHO / S&P THO unavailable / $2.88m | Non-scoringTHO / S&P THO unavailable / $0.00b | Non-scoringTHO / S&P THO unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | THO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -28.72% | 20.78% |
| Annualized return | -28.72% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | THO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -27.16% | 83.14% |
| Annualized return | -6.14% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | THO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 14.90% | 319.30% |
| Annualized return | 1.40% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.